The outcomes of surgical treatment in fistulous dacryocystitis

Basit Öğe Kaydı
dc.contributor.authorAri, S.
dc.contributor.authorCingu, K.
dc.contributor.authorSahin, A.
dc.contributor.authorOzkok, A.
dc.contributor.authorCaca, I.
dc.date.accessioned2024-04-24T17:39:57Z
dc.date.available2024-04-24T17:39:57Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractBACKGROUND AND OBJECTIVES: The aim of this study was to evaluate the outcomes of surgical management in fistulous dacryocystitis cases associated with nasolacrimal duct (NLD) obstruction. MATERIALS AND METHODS: Twenty-two patients (14 female, 8 male) with fistulous dacryocystitis were included. The patients were divided into two groups as congenital (Group I) and acquired (Group II) groups. Fistula excision (FE) together with external dacryocystorhinostomy (DCR) and bicanalicular silicon tube (FCI Ophthalmics, Marshfield Hills, MA, USA) intubation (BSTI) were performed following medical therapy (Ofloxacin 0.3 % four times a day, intravenous cefazolin (50 mg/kg/day in children and 2 g/day in adults and gentamicin (5 mg/kg/day in children and 3 mg/kg/day in adults). The groups were compared with each other in terms of preoperative medical therapy duration, time of silicone tube extubation, follow-up time, and surgical outcomes. RESULTS: Group I included five patients with acute dacryocystitis and seven patients with recurrent dacryocystitis following probing, whereas Group II was comprised of 8 acute dacryocystitis and two recurrent fistulous dacryocystitis. Mean length of preoperative medical therapy was 14.1 +/- 6.5 days for Group I and 11.9 +/- 2.5 days for Group II. Extubation of the silicone tube was performed after 4.5 +/- 1.2 months in Group I and after 4.6 +/- 1.1 months in Group II. The patients were followed up for 13.5 +/- 4.8 months in Group I and 14.3 +/- 3.7 months in Group II. There was no significant difference between the two groups in length of preoperative medical therapy, time of extubation of the silicone tube, and follow-up time (p > 0.05). Postoperatively, patency of the nasolacrimal drainage system was verified by irrigation of the lacrimal ducts and use of fluorescein eye stain. In both groups, all patients underwent surgical treatment were treated successfully. CONCLUSIONS: In fistulous dacryocystitis cases associated with the obstruction of NLD application of FE, external DCR treatment and BSTI appears as a valid surgical treatment option.en_US
dc.identifier.endpage246en_US
dc.identifier.issn1128-3602
dc.identifier.issue2en_US
dc.identifier.pmid23377815
dc.identifier.scopus2-s2.0-84878571635
dc.identifier.scopusqualityQ2
dc.identifier.startpage243en_US
dc.identifier.urihttps://hdl.handle.net/11468/21459
dc.identifier.volume17en_US
dc.identifier.wosWOS:000319224700015
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherVerduci Publisheren_US
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFistulous Dacryocystitisen_US
dc.subjectSilicone Tubeen_US
dc.subjectNasolacrimal Duct Obstructionen_US
dc.subjectSurgical Treatmenten_US
dc.titleThe outcomes of surgical treatment in fistulous dacryocystitisen_US
dc.titleThe outcomes of surgical treatment in fistulous dacryocystitis
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu